FIELD: medicine. SUBSTANCE: method involves determining the first and the second fractions of medium molecular weight blood serum peptides in patient having urgent pathology. The second fraction value is determined by measuring optical density using spectrophotometer device at 282 nm wavelength. Ratio of the first to the second fraction is calculated. The value being less than 1, heavy state of patient with negative disease dynamics is judged to be the case. EFFECT: enhanced objectivity of severity degree and disease progress dynamics prediction.
展开▼